Recruitment for the FAIR PARK II study is now closed: The last patient has been enrolled on December 5th 2019
The FAIR-PARK II 6h annual meeting was held virtually on 22nd April 2021
The FAIR-PARK II 5th annual meeting was held in Paris, France on 26th June 2019.
The FAIR-PARK II 4th annual meeting was held in Lisbon, Portugal on 15th and 16th June 2018.
The FAIR-PARK II 3rd annual meeting was held in Amsterdam, Netherlands on 26th and 27th June 2017.
The FAIR-PARK II 2nd annual meeting was held in Berlin, Germany on 23-24 June 2016.
The FAIR-PARK II kick-off meeting was held in Lille, France on 4-5 May 2015.
Recruitment for the FAIR PARK II study is now open: The first patient has been enrolled in Lille's hospital on February 9th 2016
The final list of European expert centres for the clinical trial is available since October 2015.
The final version of the protocol, as released by competent authorities and ethic national committees is available since january 2016
Patient Recruitment Countdown
16th December 2019
Patients to be recruited
The recruitment is now closed
Find out more about Fair Park II from Prof David Devos, the project coordinator
Subscribe to our newsletters
FAIR PARK II
Conservative iron chelation as a disease modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomised clinical trial of deferiprone
Scientific Coordinator: Prof David Devos
Project Manager (CHRUL): Pauline Guyon firstname.lastname@example.org
Senior Project Manager (IT): Delphine Smagghe email@example.com
Project Manager (IT): Stephanie Le Naour firstname.lastname@example.org
Centre Hospitalier Regional et Universitaire de Lille (CHRUL), 2 avenue Oscar Lambret - 59037 Lille Cedex
Inserm-Transfert (IT), 7 rue de Watt - 75013 Paris, France